Evaluation of dopaminergic function in frontotemporal dementia using 123I-FP-CIT single photon emission computed tomography

Neurodegenerative Diseases

Volumn 4, Issue 5, 2007, Pages 382-385

  Sedaghat, Fereshteh ^a,b   Gotzamani Psarrakou, Anna ^a   Dedousi, Eleni ^a   Arnaoutoglou, Marianthi ^a   Psarrakos, Kyriakos ^a   Baloyannis, Ioannis ^a   Dimitriadis, Athanasios S ^a   Baloyannis, Stavros J ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

123I FP CIT single photon emission computed tomography; DaT scan; Frontotemporal dementia; Presynaptic dopamine transporter

Indexed keywords

TRACER;

AGED; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; MALE; PRIORITY JOURNAL; PUTAMEN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; BASAL GANGLIA DISEASES; BRAIN; CORPUS STRIATUM; DEMENTIA; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; HYPOKINESIA; MALE; MUSCLE RIGIDITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 34547216229     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000105159     Document Type: Article

References (31)

1. Neary D, Snowden JS, Mann DM: Classification and description of frontotemporal dementias. Ann NY Acad Sci 2000;920:46-51.
2. Snowden JS, Neary D, Mann DA: Frontotemporal Lobar Degeneration: Frontotemporal Dementia, Progressive Aphasia, Semantic Dementia. New York, Churchill Livingstone, 1996.
3. Costa DC, Pilowsky LS, Ell PJ: Nuclear medicine in neurology and psychiatry. Lancet 1999;354:1107-1111.
4. Seibyl JP, Marek K, Sheff K, et al: Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients. J Nucl Med 1998;39:1500-1508.
5. Butler RE, Costa DC, Katona CLE: PET and SPECT imaging in the dementias; in Murray IPC, Ell PJ (eds): Nuclear Medicine in Clinical Diagnosis and Treatment. Edinburgh, Churchill Livingstone, 1995, pp 613-627.
6. Pakrasi S, Obrien JT: Emission tomography in dementia. Nucl Med Commun 2005;26:189-196.
7. Niznik HB, Fogel EF, Fassos FF, Seeman P: The dopamine transporter is absent in parkinsonian putamen and reduced in caudate nucleus . J Neurochem 1991;56:192-198.
8. 123I-FP-CIT SPECT. J Nucl Med 1999;40:753-761.
9. Kuhar MJ, Sanchez-Roa PM, Wong DF, et al: Dopamine transporter: biochemistry, pharmacology and imaging. Eur Neurol 1990;30(suppl 1):15-20.
10. 3H-2β -carbomethoxy-3β-(4- fluorophenyl) tropane. Mol Pharmacol 1989;36:518-524.
11. Kung MP, Essman WD, Frederick D, et al: IPT: A novel iodinated ligand for the CNS dopamine transporter. Synapse 1995;20:316-324.
12. Madras BK, Meltzer PC, Liang AY, Elmaleh DR, Babich J, Fischman AJ: Altropane, a SPECT or PET imaging probe for dopamine neurons. 1. Dopamine transporter binding in primate brain. Synapse 1998;29:93-104.
13. Volkow ND, Fowler JS, Gatley SJ, et al: PET evaluation of the dopamine system of the human brain. J Nucl Med 1996;37:1242-1256.
14. Lancaster JL, Rainey LH, Summerlin JL, Freitas CS, Fox PT, Evans AE, et al: Automated labeling of the human brain: a preliminary report on the development and evaluation of a forward-transform method. Hum Brain Mapp 1997;5:238-242.
15. Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, et al: Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 2000;10:120-131.
16. McKhann G, Albert M, Grossman M, Miller B, Dikson D, Trojanowski J: Clinical and pathological diagnosis of frontotemporal dementia. Arch Neurol 2001;58:1803-1809.
17. Neary D, Snowden J, Gustafson L, Passant U, Stuss D, Black S, et al: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
18. McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, et al: Dementia with Lewy bodies. Lancet Neurol 2004;3:19-28.
19. Rampello L, Cerasa S, Alvano A, Butta V, Raffaello R, Vecchio I, et al: Dementia with Lewy bodies: a review. Arch Gerontol Geriatr 2004;39:1-14.
20. Petrella J, Coleman E, Doraiswamy M: Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology 2003;226:315-336.
21. 99mTc-HMPAO in the diagnosis of Alzheimer's disease. WSEAS Trans Biol Biomed 2005;2:299-306.
22. Jagust W, Thisted R, Devous MD Sr, et al: SPECT perfusion imaging in the diagnosis of Alzheimer's disease: a clinical pathologic study. Neurology 2001;56:950-956.
23. 99mTc HMPAO SPECT data. J Neurol Neurosurg Psychiatry 2000;69:661-663.
24. Bonte FJ, Harris TS, Roney CA, Hynan LS: Differential diagnosis between Alzheimer's and frontotemporal disease by the posterior cingulate sign. J Nucl Med 2004;45:771-774.
25. Ishii K, Yamaji S, Kitagaki H, Imamura T, Hirano N, Mori E: Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology 1999;53:413-416.
26. Lobotesis K, Fenwick JD, Phipps A, et al: Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001;56:643-649.
27. Pasquier F, Lebert F, Lavenue I, Guillaume B: The clinical picture of frontotemporal dementia: diagnosis and follow-up. Dement Geriatr Cogn Disord 1999;10:10-14.
28. Sjogren M, Minthon L, Passant U, Blenew K, Wallin A: Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease. Neurobiol Aging 1998;19:379-384.
29. Nagaoka S, Arai H, Iwamoto N, et al: A juvenile case of frontotemporal dementia: neurochemical and neuropsychological investigations. Prog Neuropsychopharmacol Biol Psychiatry 1995;19:1251-1261.
30. Rinne J, Laine M, Kaasinen V, Norvasou-Heila K, Nagren K, Helenius H: Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia. Neurology 2002;58:1489-1493.
31. 123I-FP-CIT study group. Mov Disord 2000;15:503-510.